PharmTech LCGC Sciex Webinar 11.10
|Articles|May 1, 2006

Waters and Bruker announce collaboration

Waters Corporation (Milford, Massachusetts) and Bruker BioSciences Corporation (Billerica, Massachusetts) recently entered into a collaboration agreement to provide greater integration and connectivity between Waters? ACQUITY Ultra Performance LC (UPLC) system and Bruker?s mass spectrometry (MS) and nuclear magnetic resonance (NMR) products.

Waters Corporation (Milford, Massachusetts) and Bruker BioSciences Corporation (Billerica, Massachusetts) recently entered into a collaboration agreement to provide greater integration and connectivity between Waters' ACQUITY Ultra Performance LC (UPLC) system and Bruker's mass spectrometry (MS) and nuclear magnetic resonance (NMR) products.

The collaboration will allow direct support of Waters ACQUITY UPLC system in Bruker's HyStar software thus unifying control and results management to combine these technologies. The products of both companies have many applications in the discovery, development, and manufacture of pharmaceuticals, processed foods, beverages, personal care products, and in environmental and food safety laboratories.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.